Perioperatives Management der Antikoagulantien

Ther Umsch. 2016;73(10):545-549. doi: 10.1024/0040-5930/a000835.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Anticoagulants / therapeutic use*
  • Antidotes / therapeutic use
  • Dabigatran / antagonists & inhibitors
  • Factor Xa Inhibitors / adverse effects
  • Factor Xa Inhibitors / therapeutic use
  • Half-Life
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / pharmacokinetics
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Perioperative Care / methods*
  • Postoperative Hemorrhage / blood
  • Postoperative Hemorrhage / chemically induced
  • Risk
  • Thromboembolism / blood
  • Thromboembolism / prevention & control*
  • Vitamin K / antagonists & inhibitors

Substances

  • Anticoagulants
  • Antidotes
  • Factor Xa Inhibitors
  • Heparin, Low-Molecular-Weight
  • Vitamin K
  • Dabigatran